The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Self-citationProduction of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Self-citationPerz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,521
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M. S., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,520
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
Self-citationTelaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,204
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,626
Telaprevir for Retreatment of HCV Infection
Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013086 · Cited by 1,546
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
Replication of hepatitis C virus
Moradpour, D., Penin, F., & Rice, C. M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1645 · Cited by 1,336
Self-citationThe lipid droplet is an important organelle for hepatitis C virus production
Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M., & Shimotohno, K. (2007) · Nature Cell Biology · doi:10.1038/ncb1631 · Cited by 1,249
Self-citationInfectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Jacobson, I. M., Gordon, S. C., Kowdley, K. V., Yoshida, E. M., Rodriguez-Torres, M., Sulkowski, M. S., Shiffman, M. L., Lawitz, E., Everson, G., Bennett, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214854 · Cited by 1,090
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Gao, M., Nettles, R. E., Belema, M., Snyder, L. B., Nguyen, V. N., Fridell, R. A., Serrano-Wu, M. H., Langley, D. R., Sun, J.-H., O’Boyle II, D. R., et al. (2010) · Nature · doi:10.1038/nature08960 · Cited by 939
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 917
Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D., & Bienz, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5974-5984.2002 · Cited by 867
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Tsai, W.-C., Hsu, S.-D., Hsu, C.-S., Lai, T.-C., Chen, S.-J., Shen, R., Huang, Y., Chen, H.-C., Lee, C.-H., Tsai, T.-F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 814
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., & McKeating, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832180100 · Cited by 795
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Hsu, S.-H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 774
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., Hindes, R. G., & Berrey, M. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208953 · Cited by 764
Weber, P. C., Lesburg, C. A., Cable, M., Ferrari, E., Hong, Z., & Mannarino, A. F. (1999) · Nature Structural Biology · doi:10.1038/13305 · Cited by 755
Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus.
Behrens, S. E., Tomei, L., & De Francesco, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00329.x · Cited by 698
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
microRNA-122 stimulates translation of hepatitis C virus RNA
Henke, J. I., Goergen, D., Zheng, J., Song, Y., Schüttler, C. G., Fehr, C., Jünemann, C., & Niepmann, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.244 · Cited by 679
Gosert, R., Egger, D., Lohmann, V., Bartenschlager, R., Blum, H. E., Bienz, K., & Moradpour, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5487-5492.2003 · Cited by 635
Self-citationHepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., & Wakita, T. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.023 · Cited by 590
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
Bressanelli, S., Tomei, L., Roussel, A., Incitti, I., Vitale, R. L., Mathieu, M., De Francesco, R., & Rey, F. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13034 · Cited by 586
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700760104 · Cited by 533
Cellular cofactors affecting hepatitis C virus infection and replication
Randall, G., Panis, M., Cooper, J. D., Tellinghuisen, T. L., Sukhodolets, K. E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S., Lindenbach, B. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704894104 · Cited by 526
Romero-Brey, I., Merz, A., Chiramel, A., Lee, J.-Y., Chlanda, P., Haselman, U., Santarella-Mellwig, R., Habermann, A., Hoppe, S., Kallis, S., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003056 · Cited by 518
Self-citationCyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured Hepatocytes
Watashi, K., Hijikata, M., Hosaka, M., Yamaji, M., & Shimotohno, K. (2003) · Hepatology · doi:10.1053/jhep.2003.50449 · Cited by 510
Reiss, S., Rebhan, I., Backes, P., Romero-Brey, I., Erfle, H., Matula, P., Kaderali, L., Poenisch, M., Blankenburg, H., Hiet, M.-S., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2010.12.002 · Cited by 495
Self-citationStructure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
Tellinghuisen, T. L., Marcotrigiano, J., & Rice, C. M. (2005) · Nature · doi:10.1038/nature03580 · Cited by 486
Appel, N., Zayas, M., Miller, S., Krijnse-Locker, J., Schaller, T., Friebe, P., Kallis, S., Engel, U., & Bartenschlager, R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000035 · Cited by 466
Self-citationAssembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
Self-citationCell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Lindenbach, B. D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A. J., McKeating, J. A., Lanford, R. E., Feinstone, S. M., Major, M. E., Leroux-Roels, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511218103 · Cited by 448
Jopling, C. L., Schütz, S., & Sarnow, P. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.013 · Cited by 427
Chang, K.-S., Jiang, J., Cai, Z., & Luo, G. (2007) · Journal of Virology · doi:10.1128/jvi.01091-07 · Cited by 424
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus
Ago, H., Adachi, T., Yoshida, A., Yamamoto, M., Habuka, N., Yatsunami, K., & Miyano, M. (1999) · Structure · doi:10.1016/s0969-2126(00)80031-3 · Cited by 417
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Cornberg, M., Razavi, H. A., Alberti, A., Bernasconi, E., Buti, M., Cooper, C., Dalgard, O., Dillion, J. F., Flisiak, R., Forns, X., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02539.x · Cited by 411
Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex
Shimakami, T., Yamane, D., Jangra, R. K., Kempf, B. J., Spaniel, C., Barton, D. J., & Lemon, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112263109 · Cited by 397
Hepatitis C virus NS5A: tales of a promiscuous protein
Macdonald, A., & Harris, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80204-0 · Cited by 388
Hepatitis C virus infection protein network
de Chassey, B., Navratil, V, Tafforeau, L., Hiet, M. S., Aublin‐Gex, A., Agaugué, S., Meiffren, G., Pradezynski, F., Faria, B. F., Chantier, T., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.66 · Cited by 384
Masaki, T., Suzuki, R., Murakami, K., Aizaki, H., Ishii, K., Murayama, A., Date, T., Matsuura, Y., Miyamura, T., Wakita, T., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00826-08 · Cited by 376
Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T., & Lemon, S. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510727103 · Cited by 357
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
Tellinghuisen, T. L., Marcotrigiano, J., Gorbalenya, A. E., & Rice, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407787200 · Cited by 355
Guedj, J., Dahari, H., Rong, L., Sansone, N. D., Nettles, R. E., Cotler, S. J., Layden, T. J., Uprichard, S. L., & Perelson, A. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203110110 · Cited by 339
Koh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Novel Insights into Hepatitis C Virus Replication and Persistence
Bartenschlager, R., Frese, M., & Pietschmann, T. (2004) · Advances in Virus Research · doi:10.1016/s0065-3527(04)63002-8 · Cited by 307
Self-citationStructure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A
Penin, F., Brass, V., Appel, N., Ramboarina, S., Montserret, R., Ficheux, D., Blum, H. E., Bartenschlager, R., & Moradpour, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404761200 · Cited by 301
Self-citationExploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
Poordad, F., Lawitz, E., Kowdley, K. V., Cohen, D. E., Podsadecki, T., Siggelkow, S., Heckaman, M., Larsen, L., Menon, R., Koev, G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208809 · Cited by 285
Antiviral strategies in hepatitis C virus infection
Sarrazin, C., Hézode, C., Zeuzem, S., & Pawlotsky, J.-M. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60010-5 · Cited by 283
Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas Lopez, M., Lohmann, V., Luban, J., & Bartenschlager, R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000546 · Cited by 267
Self-citationSumma, V., Ludmerer, S. W., McCauley, J. A., Fandozzi, C., Burlein, C., Claudio, G., Coleman, P. J., DiMuzio, J. M., Ferrara, M., Di Filippo, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-12 · Cited by 259
Einav, S., Gerber, D., Bryson, P. D., Sklan, E. H., Elazar, M., Maerkl, S. J., Glenn, J. S., & Quake, S. R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1490 · Cited by 235
Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., & Tang, H. (2008) · Journal of Virology · doi:10.1128/jvi.02614-07 · Cited by 231
Li, Y., Masaki, T., Yamane, D., McGivern, D. R., & Lemon, S. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213515110 · Cited by 227
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Romano, K. P., Ali, A., Aydin, C., Soumana, D., Özen, A., Deveau, L. M., Silver, C., Cao, H., Newton, A., Petropoulos, C. J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002832 · Cited by 219
From Structure to Function: New Insights into Hepatitis C Virus RNA Replication
Appel, N., Schaller, T., Penin, F., & Bartenschlager, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r500026200 · Cited by 202
Self-citationBerger, K. L., Kelly, S. M., Jordan, T. X., Tartell, M. A., & Randall, G. (2011) · Journal of Virology · doi:10.1128/jvi.00059-11 · Cited by 196
Biswal, B. K., Cherney, M. M., Wang, M., Chan, L., Yannopoulos, C. G., Bilimoria, D., Nicolas, O., Bedard, J., & James, M. N. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413410200 · Cited by 195
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion
Coller, K. E., Heaton, N. S., Berger, K. L., Cooper, J. D., Saunders, J. L., & Randall, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002466 · Cited by 187
The Origin of Hepatitis C Virus
Simmonds, P. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_1 · Cited by 183
Zeisel, M. B., Felmlee, D. J., & Baumert, T. F. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_4 · Cited by 179
Hepatitis C Virus RNA Replication
Lohmann, V. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_7 · Cited by 177
Self-citationProspects for prophylactic and therapeutic vaccines against the hepatitis C viruses
Houghton, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00977.x · Cited by 177
Hanoulle, X., Badillo, A., Wieruszeski, J.-M., Verdegem, D., Landrieu, I., Bartenschlager, R., Penin, F., & Lippens, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809244200 · Cited by 169
Self-citationPeptide-based inhibitors of the hepatitis C virus serine protease
Llinàs-Brunet, M., Bailey, M., Fazal, G., Goulet, S., Halmos, T., Laplante, S., Maurice, R., Poirier, M., Poupart, M.-A., Thibeault, D., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00299-6 · Cited by 161
Liu, Z., Yang, F., Robotham, J. M., & Tang, H. (2009) · Journal of Virology · doi:10.1128/jvi.02550-08 · Cited by 159
Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus
Morikawa, K., Lange, C. M., Gouttenoire, J., Meylan, E., Brass, V., Pénin, F., & Moradpour, D. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01451.x · Cited by 158
Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes
Ferraris, P., Blanchard, E., & Roingeard, P. (2010) · Journal of General Virology · doi:10.1099/vir.0.022186-0 · Cited by 157
The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy
Luik, P., Chew, C. F., Aittoniemi, J., Chang, J. P.-E., Wentworth, P., Dwek, R. A., Biggin, P. C., Vénien‐Bryan, C., & Zitzmann, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905966106 · Cited by 156
Hepatitis c virus and host cell lipids: An intimate connection
Alvisi, G., Madan, V., & Bartenschlager, R. F. W. (2011) · RNA Biology · doi:10.4161/rna.8.2.15011 · Cited by 155
Self-citationPietschmann, T., Zayas, M., Meuleman, P., Long, G., Appel, N., Koutsoudakis, G., Kallis, S., Leroux-Roels, G. G., Lohmann, V., & Bartenschlager, R. F. W. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000475 · Cited by 146
Self-citationTrafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly
Counihan, N. A., Rawlinson, S. M., & Lindenbach, B. D. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002302 · Cited by 144
Lindenbach, B. D. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_8 · Cited by 141
Bianco, A., Reghellin, V., Donnici, L., Fenu, S., Alvarez, R. P., Baruffa, C., Peri, F., Pagani, M., Abrignani, S., Neddermann, P., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002576 · Cited by 139
Palmitoylation and Polymerization of Hepatitis C Virus NS4B Protein
Yu, G., Lee, K. J., Gao, L., & Lai, M. M. C. (2006) · Journal of Virology · doi:10.1128/jvi.00053-06 · Cited by 137
Arnold, J. J., Sharma, S. D., Feng, J. Y., Ray, A. S., Smidansky, E. D., Kireeva, M. L., Cho, A., Perry, J. K., Vela, J. E., Park, Y., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003030 · Cited by 135
Brass, V., Berke, J. M., Montserret, R., Blum, H. E., Pénin, F., & Moradpour, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807298105 · Cited by 131
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
Thimme, R., Binder, M., & Bartenschlager, R. F. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00319.x · Cited by 128
Self-citationEfficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
Saeed, M., Scheel, T. K. H., Gottwein, J. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01256-12 · Cited by 126
Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory
Gouttenoire, J., Pénin, F., & Moradpour, D. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.640 · Cited by 125
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
Jacobson, I. M., Davis, G. L., El‐Serag, H. B., Negro, F., & TREPO, C. G. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.032 · Cited by 122
Hepatitis C Virus RNA Translation
Niepmann, M. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_6 · Cited by 119
Verdegem, D., Badillo, A., Wieruszeski, J., Landrieu, I., Leroy, A., Bartenschlager, R. F. W., Pénin, F., Lippens, G. M., & Hanoulle, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182436 · Cited by 105
Self-citationGouttenoire, J., Castet, V., Montserret, R., Arora, N., Raussens, V., Ruysschaert, J., Diesis, É., Blum, H. E., Pénin, F., & Moradpour, D. (2009) · Journal of Virology · doi:10.1128/jvi.02663-08 · Cited by 98
Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
Powdrill, M. H., Bernatchez, J. A., & Götte, M. (2010) · Viruses · doi:10.3390/v2102169 · Cited by 98
Structural and Functional Analysis of Hepatitis C Virus Strain JFH1 Polymerase
Simister, P. C., Schmitt, M. M., Geitmann, M., Wicht, O., Danielson, U. H., Klein, R., Bressanelli, S., & Lohmann, V. (2009) · Journal of Virology · doi:10.1128/jvi.01008-09 · Cited by 93
Self-citationNatural history of chronic hepatitis C virus infection
Ascione, A., Tartaglione, M. T., & Costanzo, G. G. D. (2007) · Digestive and Liver Disease · doi:10.1016/s1590-8658(07)80003-x · Cited by 74
Einav, S., Sklan, E. H., Moon, H. M., Gehrig, E., Liu, P., Hao, Y., Lowe, A. W., & Glenn, J. S. (2007) · Hepatology · doi:10.1002/hep.22108 · Cited by 66
Steinmann, E., & Pietschmann, T. (2010) · Viruses · doi:10.3390/v2092078 · Cited by 57
Phan, T. G., Kohlway, A. S., Dimberu, P., Pyle, A. M., & Lindenbach, B. D. (2010) · Journal of Virology · doi:10.1128/jvi.01889-10 · Cited by 56
Turning Hepatitis C into a Real Virus
Murray, C. L., & Rice, C. M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102954 · Cited by 56
Canonical 3′-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase
Shim, J., Larson, G., Lai, V. C. H., Naim, S., & Wu, J. Z. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00007-x · Cited by 49
Update on alisporivir in treatment of viral hepatitis C
Flisiak, R., Jaroszewicz, J., Flisiak, I., & Łapiński, T. W. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.658641 · Cited by 47
Recent Advances in Hepatitis C Virus Cell Entry
Bartosch, B., & Dubuisson, J. (2010) · Viruses · doi:10.3390/v2030692 · Cited by 36
Direct-acting and host-targeting HCV inhibitors: current and future directions
Chatel‐Chaix, L., Germain, M.-A., Götte, M., & Lamarre, D. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.08.002 · Cited by 31
Progress In The Development Of Anti-Hepatitis C Virus Nucleoside And Nucleotide Prodrugs
Madela, K., & McGuigan, C. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.10 · Cited by 24
Cited by
A perspective on multi‐target drug discovery and design for complex diseases
Ramsay, R. R., Popovic‐Nikolic, M. R., Nikolic, K., Uliassi, E., & Bolognesi, M. L. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0181-2 · Cited by 718
Rewiring cellular networks by members of the Flaviviridae family
Neufeldt, C. J., Cortese, M., Acosta, E. G., & Bartenschlager, R. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.170 · Cited by 409
Self-citation
Metadata
- Authors
- Bartenschlager, R., Lohmann, V., & Penin, F.
- Venue
- Nature Reviews Microbiology
- Published
- 2013-06-10
- Volume
- 11
- Issue
- 7
- Pages
- 482-496
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2014290325
- Cited by
- 402
- References
- 111
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.